Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California.
Department of Otolaryngology-Head and Neck Surgery, Sutter Medical Foundation, Davis, California.
JAMA Otolaryngol Head Neck Surg. 2024 Aug 1;150(8):651-657. doi: 10.1001/jamaoto.2024.1400.
Nodule rupture is a rare but serious complication of thyroid radiofrequency ablation (RFA). With growing adoption of thyroid RFA across the US, an understanding of thyroid nodule rupture (TNR) is crucial for recognition, management, and, ultimately, prevention.
To determine procedural and patient factors that may contribute to TNR and describe experiences in managing TNR while synthesizing existing literature.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective case series examined all RFA procedures for benign thyroid nodules performed by 2 attending physicians at a single academic referral center between December 2019 and January 2024. A total of 298 consecutive patients underwent RFA for benign thyroid nodules. Criteria for offering RFA included nodules with 2 benign fine-needle aspirations, no suspicious ultrasonography features, a greatest dimension of 2 cm or greater, compressive or cosmetic concerns, and accessibility to a straight needle.
All RFAs were performed using ultrasonography guidance using the moving-shot technique and a 7-mm or 10-mm active tip.
The primary outcome was TNR, and measures were procedure, nodule, and patient characteristics that may have contributed to its pathogenesis. Secondary outcomes were nodule volume reduction, thyroid function, and management and sequelae of TNR. The hypothesis on the pathogenesis of TNR was formed before data collection.
Six of 298 patients (2%; 4 women [67%]) with a mean age of 48.5 years (range, 34-65 years) experienced TNR for a mean of 36 days postprocedure (range, 19-54 days). The mean (SD) initial nodule volume among patients with TNR was 31.45 (16.52) mL, and 3 of 6 patients (50%) underwent prior lobectomy. All ruptures were anterior. All patients were treated conservatively, and none required surgery. Five patients recovered completely; the sixth and most recent patient was healing as of last follow-up.
There are limited data on the etiology and optimal management of TNR. These 6 cases of anterior rupture suggest that a potential contributor to TNR is thermal and mechanical trauma exerted at the fulcrum point during the moving-shot technique. The use of a smaller active tip (eg, 7 mm) and cessation of energy delivery before this point may help avoid TNR. More robust reporting of this complication may clarify risk factors for and enhance prevention of TNR.
结节破裂是甲状腺射频消融(RFA)的一种罕见但严重的并发症。随着美国甲状腺 RFA 的广泛采用,了解甲状腺结节破裂(TNR)对于识别、管理,最终预防至关重要。
确定可能导致 TNR 的程序和患者因素,并描述在综合现有文献的同时管理 TNR 的经验。
设计、设置和参与者:这项回顾性病例系列研究检查了 2019 年 12 月至 2024 年 1 月期间,在一个学术转诊中心由 2 名主治医生进行的所有用于良性甲状腺结节的 RFA 程序。共有 298 名连续患者接受了良性甲状腺结节的 RFA。提供 RFA 的标准包括 2 次良性细针抽吸、无可疑超声特征、最大直径为 2cm 或更大、有压迫或美容问题、以及可触及直针的结节。
所有的 RFA 都是在超声引导下使用移动射击技术和 7mm 或 10mm 活性尖端进行的。
主要结果是 TNR,措施是可能导致其发病机制的程序、结节和患者特征。次要结果是结节体积减少、甲状腺功能以及 TNR 的管理和后果。关于 TNR 发病机制的假设是在数据收集之前形成的。
298 名患者中有 6 名(2%;4 名女性[67%])发生 TNR,平均年龄为 48.5 岁(范围 34-65 岁),平均术后 36 天(范围 19-54 天)出现 TNR。TNR 患者的初始结节体积平均为 31.45(16.52)mL,6 名患者中有 3 名(50%)接受了先前的叶切除术。所有破裂均在前部。所有患者均接受保守治疗,无患者需要手术。5 名患者完全康复;最近的第 6 名患者在最后一次随访时正在康复。
关于 TNR 的病因和最佳治疗方法的数据有限。这 6 例前侧破裂提示,TNR 的一个潜在促成因素是在移动射击技术的支点处施加的热和机械创伤。使用较小的活性尖端(例如 7mm)并在此点之前停止能量输送可能有助于避免 TNR。更全面地报告这种并发症可能会澄清 TNR 的风险因素并加强预防。